Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5421]

Sacituzumab govitecan in patients with previously treated metastatic urothelial...

Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA

Sacituzumab govitecan in patients with previously treated metastatic urothelial cancer ( Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA )

Updates from KEYNOTE 57: Pembrolizumab for patients with bladder cancer

Dr Arjun Balar - NYU Langone Health, New York City, USA

Updates from KEYNOTE 57: Pembrolizumab for patients with bladder cancer ( Dr Arjun Balar - NYU Langone Health, New York City, USA )

CHEIRON study: Docetaxel plus enzalutamide versus docetaxel as first-line...

Dr Orazio Caffo - Santa Chiara Hospital, Trento, Italy

CHEIRON study: Docetaxel plus enzalutamide versus docetaxel as first-line chemotherapy for patients with mCRPC ( Dr Orazio Caffo - Santa Chiara Hospital, Trento, Italy )

BGICC 2019 ( )

Positive feedback of clinical trials, research and patient outcomes

Prof Carlos Barrios - Pontifica Universidade Catolica de Rio Grande do Sul...

Positive feedback of clinical trials, research and patient outcomes ( Prof Carlos Barrios - Pontifica Universidade Catolica de Rio Grande do Sul, Porto Alegre, Brazil )

When to increase and decrease burden of treatment for breast cancer patients

Prof Pierre Conte - Istituto Oncologico Veneto, Padova, Italy

When to increase and decrease burden of treatment for breast cancer patients ( Prof Pierre Conte - Istituto Oncologico Veneto, Padova, Italy )

Neoadjuvant hormonal treatment for luminal breast cancer: Rationale, evidence...

Prof Hope Rugo - University of California, San Francisco, USA

Neoadjuvant hormonal treatment for luminal breast cancer: Rationale, evidence and outcome ( Prof Hope Rugo - University of California, San Francisco, USA )

APT for HER2 breast cancer patients with small tumours

Prof Nagi El Saghir - American University of Beirut, Beirut, Lebanon

APT for HER2 breast cancer patients with small tumours ( Prof Nagi El Saghir - American University of Beirut, Beirut, Lebanon )

Can we cure cervical cancer?

Prof Murat Gultekin - Hacettepe University, Ankara, Turkey

Can we cure cervical cancer? ( Prof Murat Gultekin - Hacettepe University, Ankara, Turkey )

History and current status of breast cancer treatment in Sweden

Prof Kerstin Sandelin - Karolinska Institutet, Solna, Sweden

History and current status of breast cancer treatment in Sweden ( Prof Kerstin Sandelin - Karolinska Institutet, Solna, Sweden )

New FIGO staging in vulval and cervical cancer

Prof Sean Kehoe - University of Birmingham, Birmingham, UK

New FIGO staging in vulval and cervical cancer ( Prof Sean Kehoe - University of Birmingham, Birmingham, UK )

Where does neoadjuvant chemotherapy in advanced ovarian cancer fit in clinical...

Prof Sean Kehoe - University of Birmingham, Birmingham, UK

Where does neoadjuvant chemotherapy in advanced ovarian cancer fit in clinical practice? ( Prof Sean Kehoe - University of Birmingham, Birmingham, UK )

More from ecancer